Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging
Guangling Yang1, Ruipeng Song1, Limin Wang1
1Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
Abstract:
Long non-coding RNA P73 antisense RNA 1 T (lncRNA TP73-AS1) has been shown to involve in the progression of numerous tumors. Nevertheless, the expression as well as the functional mechanisms of TP73-AS1 in osteosarcoma (OS) are still largely unknown. This study aimed to explore the roles and underlying mechanism of TP73-AS1 in OS progression. In thye present study, TP73-AS1 expression was significantly increased in OS tissues and cell lines. High TP73-AS1 expression was associated with poor overall survival of OS patients. TP73-AS1 knockdown suppressed OS cells proliferation and invasion in vitro as well as tumor growth in vivo. Furthermore, we identified that miR-142 could act as a direct target for TP73-AS1 and miR-142 inhibition reversed the suppression of OS cells proliferation and invasion induced by TP73-AS1 knockdown. In addition, we showed that TP73-AS1 could function as a sponge of miR-142 to positively regulate Rac1 in OS cells. Thus, our data suggested that TP73-AS1 served as an oncogenic lncRNA in OS progression, and could be regarded as an efficient therapeutic target in the treatment of OS.
Insights
Long non-coding RNA TP73-AS1 is elevated in osteosarcoma (OS) and promotes tumor growth by sponging miR-142, leading to increased Rac1. Targeting TP73-AS1 may offer a new therapeutic strategy for OS.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play critical roles in various cancers.
- The role and mechanism of lncRNA TP73-AS1 in osteosarcoma (OS) remain largely uncharacterized.
- Understanding lncRNA functions is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the expression and functional role of lncRNA TP73-AS1 in osteosarcoma.
- To elucidate the underlying molecular mechanism of TP73-AS1 in OS progression.
- To evaluate TP73-AS1 as a potential therapeutic target for osteosarcoma.
Main Methods:
- Quantitative real-time PCR to assess TP73-AS1 expression in OS tissues and cell lines.
- In vitro assays (proliferation, invasion) and in vivo tumor growth experiments following TP73-AS1 knockdown.
- MiRNA target prediction and validation (e.g., luciferase reporter assay) to confirm miR-142 as a direct target.
- Western blot analysis to assess the regulation of downstream targets like Rac1.
Main Results:
- TP73-AS1 expression was significantly upregulated in OS tissues and cell lines compared to normal controls.
- High TP73-AS1 expression correlated with poorer overall survival in OS patients.
- Knockdown of TP73-AS1 inhibited OS cell proliferation and invasion in vitro and suppressed tumor growth in vivo.
- TP73-AS1 directly targets and sponges miR-142, and inhibition of miR-142 reversed the effects of TP73-AS1 knockdown.
- TP73-AS1 positively regulates Rac1 expression in OS cells via sponging miR-142.
Conclusions:
- TP73-AS1 acts as an oncogenic lncRNA in osteosarcoma progression.
- The TP73-AS1/miR-142/Rac1 axis is a key pathway in OS development.
- TP73-AS1 represents a promising therapeutic target for osteosarcoma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Feedback Inhibition
Cells Coordinate Growth and Proliferation
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...

